DNA sensing of dendritic cells in cancer immunotherapy
W Qian, J Ye, S Xia - Frontiers in Molecular Biosciences, 2024 - frontiersin.org
Dendritic cells (DCs) are involved in the initiation and maintenance of immune responses
against malignant cells by recognizing conserved pathogen-associated molecular patterns …
against malignant cells by recognizing conserved pathogen-associated molecular patterns …
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of …
CC Ghosh, L Cournoyer, Y Liu… - Journal for …, 2024 - pmc.ncbi.nlm.nih.gov
Background Toll-like receptor 9 (TLR9) agonists induce inflammatory responses that
promote the killing of infectious micro-organisms, cancer cells and develop adaptive …
promote the killing of infectious micro-organisms, cancer cells and develop adaptive …
A Review on Innovative Drug Delivery Platforms
SK Kosuru, VS Rao, K Annapurna, BNL Siripalli… - Journal of Clinical and …, 2024 - jcpr.in
In recent years, the field of drug delivery has undergone a transformative shift with the
introduction of innovative platforms that transcend conventional methods, providing accurate …
introduction of innovative platforms that transcend conventional methods, providing accurate …